Oral anticoagulation across diabetic subtypes in patients with newly diagnosed atrial fibrillation: a report from the GARFIELD-AF registry
AIMS: This study aims to describe both management and prognosis of patients with diabetes mellitus (DM) and newly diagnosed atrial fibrillation (AF), overall as well as by antidiabetic treatment, and to assess the influence of oral anticoagulation (OAC) on outcomes by DM status. METHODS: The study p...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2023
|
| In: |
Diabetes, obesity and metabolism
Year: 2023, Jahrgang: 25, Heft: 10, Pages: 3040-3053 |
| ISSN: | 1463-1326 |
| DOI: | 10.1111/dom.15202 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.1111/dom.15202 Verlag, kostenfrei, Volltext: https://dom-pubs.pericles-prod.literatumonline.com/doi/10.1111/dom.15202 
|
| Verfasserangaben: | Jean-Pierre Bassand, Saverio Virdone, A. John Camm, Keith A.A. Fox, Samuel Z. Goldhaber, Shinya Goto, Sylvia Haas, Werner Hacke, Gloria Kayani, Matyas Keltai, Frank Misselwitz, Karen S. Pieper, Alexander G.G. Turpie, Freek W.A. Verheugt, Ajay K. Kakkar, for the GARFIELD-AF Investigators |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1871026393 | ||
| 003 | DE-627 | ||
| 005 | 20241206185122.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231123s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/dom.15202 |2 doi | |
| 035 | |a (DE-627)1871026393 | ||
| 035 | |a (DE-599)KXP1871026393 | ||
| 035 | |a (OCoLC)1425209292 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Bassand, Jean-Pierre |e VerfasserIn |0 (DE-588)1115826379 |0 (DE-627)870060996 |0 (DE-576)477962564 |4 aut | |
| 245 | 1 | 0 | |a Oral anticoagulation across diabetic subtypes in patients with newly diagnosed atrial fibrillation |b a report from the GARFIELD-AF registry |c Jean-Pierre Bassand, Saverio Virdone, A. John Camm, Keith A.A. Fox, Samuel Z. Goldhaber, Shinya Goto, Sylvia Haas, Werner Hacke, Gloria Kayani, Matyas Keltai, Frank Misselwitz, Karen S. Pieper, Alexander G.G. Turpie, Freek W.A. Verheugt, Ajay K. Kakkar, for the GARFIELD-AF Investigators |
| 264 | 1 | |c 2023 | |
| 300 | |b Illustrationen | ||
| 300 | |a 14 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Online veröffentlicht: 12. Juli 2023 | ||
| 500 | |a Gesehen am 23.11.2023 | ||
| 520 | |a AIMS: This study aims to describe both management and prognosis of patients with diabetes mellitus (DM) and newly diagnosed atrial fibrillation (AF), overall as well as by antidiabetic treatment, and to assess the influence of oral anticoagulation (OAC) on outcomes by DM status. METHODS: The study population comprised 52 010 newly diagnosed patients with AF, 11 542 DM and 40 468 non-DM, enrolled in the GARFIELD-AF registry. Follow-up was truncated at 2 years after enrolment. Comparative effectiveness of OAC versus no OAC was assessed by DM status using a propensity score overlap weighting scheme and weights were applied to Cox models. RESULTS: Patients with DM [39.3% oral antidiabetic drug (OAD), 13.4% insulin ± OAD, 47.2% on no antidiabetic drug] had higher risk profile, OAC use, and rates of clinical outcomes compared with patients without DM. OAC use was associated in patients without DM and patients with DM with lower risk of all-cause mortality [hazard ratio 0.75 (0.69-0.83), 0.74 (0.64-0.86), respectively] and stroke/systemic embolism (SE) [0.69 (0.58-0.83), 0.70 (0.53-0.93), respectively]. The risk of major bleeding with OAC was similarly increased in patients without DM and those with DM [1.40 (1.14-1.71), 1.37 (0.99-1.89), respectively]. Patients with insulin-requiring DM had a higher risk of all-cause mortality and stroke/SE [1.91 (1.63-2.24)], [1.57 (1.06-2.35), respectively] compared with patients without DM, and experienced significant risk reductions of all-cause mortality and stroke/SE with OAC [0.73 (0.53-0.99); 0.50 (0.26-0.97), respectively]. CONCLUSIONS: In both patients with DM and patients without DM with AF, OAC was associated with lower risk of all-cause mortality and stroke/SE. Patients with insulin-requiring DM derived significant benefit from OAC. | ||
| 650 | 4 | |a administration, oral | |
| 650 | 4 | |a anticoagulants | |
| 650 | 4 | |a atrial fibrillation | |
| 650 | 4 | |a cardiovascular disease | |
| 650 | 4 | |a cohort study | |
| 650 | 4 | |a diabetes mellitus | |
| 650 | 4 | |a Humans | |
| 650 | 4 | |a Insulins | |
| 650 | 4 | |a observational study | |
| 650 | 4 | |a oral anticoagulants | |
| 650 | 4 | |a Registries | |
| 650 | 4 | |a Risk Factors | |
| 650 | 4 | |a Stroke | |
| 650 | 4 | |a type 2 diabetes | |
| 700 | 1 | |a Virdone, Saverio |e VerfasserIn |4 aut | |
| 700 | 1 | |a Camm, A. John |e VerfasserIn |4 aut | |
| 700 | 1 | |a Fox, Keith A. A. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Goldhaber, Samuel Z. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Goto, Shinya |e VerfasserIn |4 aut | |
| 700 | 1 | |a Haas, Sylvia |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hacke, Werner |d 1948- |e VerfasserIn |0 (DE-588)12021699X |0 (DE-627)080530346 |0 (DE-576)164358854 |4 aut | |
| 700 | 1 | |a Kayani, Gloria |e VerfasserIn |4 aut | |
| 700 | 1 | |a Keltai, Matyas |e VerfasserIn |4 aut | |
| 700 | 1 | |a Misselwitz, Frank |e VerfasserIn |4 aut | |
| 700 | 1 | |a Pieper, Karen S. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Turpie, Alexander G. G. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Verheugt, Freek W. A. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kakkar, Ajay K. |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Diabetes, obesity and metabolism |d Oxford [u.a.] : Wiley-Blackwell, 1999 |g 25(2023), 10, Seite 3040-3053 |h Online-Ressource |w (DE-627)320440982 |w (DE-600)2004918-3 |w (DE-576)091142679 |x 1463-1326 |7 nnas |a Oral anticoagulation across diabetic subtypes in patients with newly diagnosed atrial fibrillation a report from the GARFIELD-AF registry |
| 773 | 1 | 8 | |g volume:25 |g year:2023 |g number:10 |g pages:3040-3053 |g extent:14 |a Oral anticoagulation across diabetic subtypes in patients with newly diagnosed atrial fibrillation a report from the GARFIELD-AF registry |
| 856 | 4 | 0 | |u https://doi.org/10.1111/dom.15202 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://dom-pubs.pericles-prod.literatumonline.com/doi/10.1111/dom.15202 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20231123 | ||
| 993 | |a Article | ||
| 994 | |a 2023 | ||
| 998 | |g 12021699X |a Hacke, Werner |m 12021699X:Hacke, Werner |d 910000 |d 911100 |d 50000 |e 910000PH12021699X |e 911100PH12021699X |e 50000PH12021699X |k 0/910000/ |k 1/910000/911100/ |k 0/50000/ |p 8 | ||
| 999 | |a KXP-PPN1871026393 |e 4416586949 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"id":{"eki":["1871026393"],"doi":["10.1111/dom.15202"]},"physDesc":[{"extent":"14 S.","noteIll":"Illustrationen"}],"recId":"1871026393","note":["Online veröffentlicht: 12. Juli 2023","Gesehen am 23.11.2023"],"title":[{"title_sort":"Oral anticoagulation across diabetic subtypes in patients with newly diagnosed atrial fibrillation","subtitle":"a report from the GARFIELD-AF registry","title":"Oral anticoagulation across diabetic subtypes in patients with newly diagnosed atrial fibrillation"}],"person":[{"display":"Bassand, Jean-Pierre","family":"Bassand","roleDisplay":"VerfasserIn","role":"aut","given":"Jean-Pierre"},{"roleDisplay":"VerfasserIn","display":"Virdone, Saverio","family":"Virdone","role":"aut","given":"Saverio"},{"family":"Camm","display":"Camm, A. John","roleDisplay":"VerfasserIn","given":"A. John","role":"aut"},{"roleDisplay":"VerfasserIn","display":"Fox, Keith A. A.","family":"Fox","given":"Keith A. A.","role":"aut"},{"given":"Samuel Z.","role":"aut","roleDisplay":"VerfasserIn","family":"Goldhaber","display":"Goldhaber, Samuel Z."},{"roleDisplay":"VerfasserIn","display":"Goto, Shinya","family":"Goto","given":"Shinya","role":"aut"},{"given":"Sylvia","role":"aut","family":"Haas","display":"Haas, Sylvia","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","display":"Hacke, Werner","family":"Hacke","role":"aut","given":"Werner"},{"roleDisplay":"VerfasserIn","display":"Kayani, Gloria","family":"Kayani","role":"aut","given":"Gloria"},{"roleDisplay":"VerfasserIn","family":"Keltai","display":"Keltai, Matyas","given":"Matyas","role":"aut"},{"role":"aut","given":"Frank","display":"Misselwitz, Frank","family":"Misselwitz","roleDisplay":"VerfasserIn"},{"role":"aut","given":"Karen S.","family":"Pieper","display":"Pieper, Karen S.","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","family":"Turpie","display":"Turpie, Alexander G. G.","given":"Alexander G. G.","role":"aut"},{"given":"Freek W. A.","role":"aut","roleDisplay":"VerfasserIn","display":"Verheugt, Freek W. A.","family":"Verheugt"},{"role":"aut","given":"Ajay K.","family":"Kakkar","display":"Kakkar, Ajay K.","roleDisplay":"VerfasserIn"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedDisp":"2023","dateIssuedKey":"2023"}],"name":{"displayForm":["Jean-Pierre Bassand, Saverio Virdone, A. John Camm, Keith A.A. Fox, Samuel Z. Goldhaber, Shinya Goto, Sylvia Haas, Werner Hacke, Gloria Kayani, Matyas Keltai, Frank Misselwitz, Karen S. Pieper, Alexander G.G. Turpie, Freek W.A. Verheugt, Ajay K. Kakkar, for the GARFIELD-AF Investigators"]},"relHost":[{"note":["Gesehen am 28.10.03"],"part":{"pages":"3040-3053","volume":"25","text":"25(2023), 10, Seite 3040-3053","issue":"10","extent":"14","year":"2023"},"title":[{"title":"Diabetes, obesity and metabolism","title_sort":"Diabetes, obesity and metabolism"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"id":{"doi":["10.1111/(ISSN)1463-1326"],"eki":["320440982"],"issn":["1463-1326"],"zdb":["2004918-3"]},"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"recId":"320440982","origin":[{"dateIssuedDisp":"1999-","publisher":"Wiley-Blackwell ; Blackwell ; Blackwell Science","dateIssuedKey":"1999","publisherPlace":"Oxford [u.a.] ; Oxford [u.a.] ; Oxford"}],"pubHistory":["1.1999 -"],"disp":"Oral anticoagulation across diabetic subtypes in patients with newly diagnosed atrial fibrillation a report from the GARFIELD-AF registryDiabetes, obesity and metabolism"}]} | ||
| SRT | |a BASSANDJEAORALANTICO2023 | ||